-
NEJM: Can diabetic patients lower blood lipids, can it reduce cardiovascular risk? The latest research says so
Time of Update: 2023-01-06
Recently, the New England Journal of Medicine (NEJM) published the results of the PROMINENT trial online, confirming that although the new drug Pemafibrate can reduce triglyceride levels in patients with type 2 diabetes, it does not reduce the risk of myocardial infarction, stroke or cardiovascular disease death 。 Lead author Dr Aruna Pradhan, from the Department of Cardiology at Brigham and Women's Hospital, said: "The results are puzzling, but at the same time have important clinical value".
-
NEJM: Can diabetic patients lower blood lipids, can it reduce cardiovascular risk? The latest research says so
Time of Update: 2023-01-06
Recently, the New England Journal of Medicine (NEJM) published the results of the PROMINENT trial online, confirming that although the new drug Pemafibrate can reduce triglyceride levels in patients with type 2 diabetes, it does not reduce the risk of myocardial infarction, stroke or cardiovascular disease death 。 Lead author Dr Aruna Pradhan, from the Department of Cardiology at Brigham and Women's Hospital, said: "The results are puzzling, but at the same time have important clinical value".
-
In 2018, global demand for military and aerospace optical cables will exceed $1.8 billion
Time of Update: 2022-12-28
Based on end-use, the space segment of the military and aerospace fiber optic cable market is expected to grow at the highest CAGR during the forecast period.
-
PVC market sentiment is calm futures consolidation
Time of Update: 2022-12-12
Guangzhou PVC market atmosphere is calm, downstream demand is general, the overall transaction is tepid, the mainstream price fluctuation is not large, some real orders give profits, ordinary 5 type calcium carbide mainstream transaction 7160-7250 yuan / ton.
-
PVC morning review on March 21
Time of Update: 2022-12-05
PVCDownstream factories have limited enthusiasm for entering the market, procurement efforts are weak, and terminal demand shows no signs of improvement.
PVCDownstream factories have limited enthusiasm for entering the market, procurement efforts are weak, and terminal demand shows no signs of improvement.
-
Cholesterol and diabetes medications may reduce the risk of degenerative eye disease in old age
Time of Update: 2022-11-14
A comprehensive analysis of the available evidence, published online in the British Journal of Ophthalmology, found that regular use of cholesterol-lowering and type 2 diabetes medications may reduce the risk of age-related degenerative eye disease (AMD).
-
JTO: KRAS mutation, STK11 and KEAP1 mutations in lung adenocarcinoma significantly reduce immune efficacy
Time of Update: 2022-10-19
Since STK11 and KEAP1 mutations often occur co-existing in NSCLC, this study sought to determine whether individual gene mutations independently affect immunotherapy outcomes and to understand whether this effect has the same mechanism of action in KRAS mutations as well as in KRAS wild-type patients.
-
What is the "versatility" of a portable microplate reader
Time of Update: 2022-10-12
When the enzyme conjugate and the substrate of the enzyme are added sequentially, a coloring reaction occurs, and the degree of coloration of the microplate reader is related to the amount of antibody to be tested in the sample to be tested, from which qualitative or quantitative detection results can be obtained.
-
Breast cancer cells "chaotic" metastasis, how to choose staging and treatment
Time of Update: 2022-10-01
Recently, a case report published in the BMC sub-journal detailed the clinical, morphological, pathological and immunohistochemical characteristics of a case of breast cancer with contralateral cervical lymph node metastasis, and discussed the treatment method in combination with the current research, which may be inspiring to everyone ~ screenshot of the first page of the studyBasic facts of the casePatient, female, 30 years of age: right breast mass for 5 months, lymphadenopathy in left neck for 5 days.
-
The first special medical food enterprise in Hainan Province was approved and put into operation
Time of Update: 2022-08-31
(Gao Jun) "China Food News" (Version 06, June 2, 2021)(Editor in charge: Zhu Meiqiao) We learned from the Hainan Provincial Market Supervision and Administration Bureau that the first enterprise of formula food for special medical purposes in Hainan has recently been approved and put into production .
-
Weekly International Animal Epidemic Update - Issue 353 (March 31-April 6
Time of Update: 2022-05-14
34 outbreaks of highly pathogenic avian influenza (H5N1 subtype) in wild birds and 1 poultry in Germany On March 30 and 31 and April 4 and 6, Germany reported that 35 wild birds and 1 poultry H5N1 subtype highly pathogenic avian influenza had occurred in 6 places including Brandenburg State, 66 wild birds were infected and died, 79 One turkey died and 5,871 were culled .
-
Characteristics and application of special coatings for iron mold sand-coated molds
Time of Update: 2022-05-10
4. Good sintering properties and peeling propertiesAccording to the characteristics of the iron mold sand coating process, such as fast cooling speed, through scientific control of the types and proportions of refractory aggregates and additives in the coating, the coating can form a complete glass body, prevent the molten metal from penetrating into the sand mold, and reduce the phenomenon of sand sticking on the surface of the casting.
-
BMS Oral Kinase Inhibitor Inrebic Approved by UK NICE for Myelofibrosis
Time of Update: 2022-02-26
CompilenewbornThe UK National Institute for Health and Clinical Excellence (NICE) recently issued a final assessment decision (FAD) recommending the use of Bristol-Myers Squibb's oral kinase inhibitor Inrebic (fedratinib) in the NHS for the treatment of bone marrow Fibrosis, a rare blood cancer that affects the bone marrow and disrupts the production of blood cells in the body .
-
Unexpectedly, "fat" is actually good for improving type 2 diabetes
Time of Update: 2022-01-24
By studying the cellular mechanisms at work, the researchers discovered how the cycle of fat storage and mobilization allows cells to adapt to excess sugar .
Thanks to these released fat molecules, cells adapt to the excess sugar, maintaining near-normal insulin secretion .
-
Nine potential blockbuster treatments expected to be approved in 2022
Time of Update: 2022-01-09
In the “Lancet” magazine last October, Eli Lilly published the detailed phase 3 clinical results of the innovative treatment-in adult patients with type 2 diabetes with increased cardiovascular risk, compared with insulin glargine, three All doses of tirzepatide showed better curative effect, and reduced the level of glycated hemoglobin (A1C) (maximum dose 2.
